Komipharm International Co., Ltd. (KOSDAQ: A041960) announced a private placement of 11th series unregistered unsecured private convertible bonds for gross proceeds of KRW 9,000,000,000 on January 12, 2017. The transaction included participation from December 16, 2019 for KRW 2,900,000,000, Shinan Savings and Finance Co., Ltd. for KRW 2,000,000,000, and Hands Partners Limited Company for KRW 1,100,000,000. The bonds will mature on January 16, 2020.

The bonds are zero-coupon and have yield to maturity of 3%. The bonds will be fully convertible into 267,650 shares of the company at a fixed conversion price of KRW 33,626 per share between the periods of January 16, 2018 to December 16, 2019.